MedTrace Logo

REgiStry Of the NAtural History of recurreNt periCarditis in pEdiatric and Adult Patients

NCT04687358 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2026-02-17

No results posted yet for this study

Summary

The registry will focus on furthering the understanding of the natural history of recurrent pericarditis (RP), as well as document RP-related clinical, health-related quality of life (HRQoL), and economic burden and will assist the medical community to refine or develop data-driven recommendations for clinical management of RP patients to optimize clinical outcomes. It also aims to generate data in support of the impact of rilonacept on clinical outcomes in a real-world population.

Conditions

  • Recurrent Pericarditis

Sponsors & Collaborators

  • Kiniksa Pharmaceuticals (UK), Ltd.

    collaborator INDUSTRY

  • Kiniksa Pharmaceuticals International, plc

    lead INDUSTRY

Principal Investigators

  • John F Paolini, MD, PhD · Kiniksa Pharmaceuticals Corp

Eligibility

Min Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-16
Primary Completion
2029-03-31
Completion
2029-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04687358 on ClinicalTrials.gov